HOPX and acute myeloid leukemia: In overall survival (Figure 4), low expression HOPX predicted good survival in AML, brain lower grade glioma, cervical squamous cell carcinoma and endocervical adenocarcinoma, colon adenocarcinoma, LUAD, lung squamous cell carcinoma, and STAD.